MetaCap

Eledon Pharmaceuticals Statistics

NASDAQ: ELDNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.78-0.12 (-6.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Eledon Pharmaceuticals by the numbers

Eledon Pharmaceuticals has a market capitalization of $150.3 million based on 84.46M shares outstanding. With trailing EPS of $-0.73, Eledon Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.8% below its 50-day average and 43.0% below its 200-day average.

Average daily trading volume is 931.77K shares, or about $1.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ELDN valuation vs. peer median

ELDN compared with the median of 8 peer companies
MetricELDNPeer medianDifference
Market cap$150.34M$148.17M+1%
Avg. volume931.77K464.38K+101%

Peer median across 8 companies: RNA, IFRX, VRXA, PRQR, ORMP, BBOT, EMIS, ALXO.

Valuation

Price and trading

Previous close
1.90
Open
1.87
Day range
1.76 – 2.00
52-week range
1.39 – 4.49
52-week change
+23.61%
Beta
—
Volume
1.29M

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
150.34M
Forward Pe
-2.35
Eps
-0.73
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.49
Week52 Low
1.39
Avg Volume
931.77K
Shares Outstanding
84.46M
Ma50
2.47
Ma200
3.12
Earnings Date
Nov 13, 2026
Pct From52w High
-60.36%
Pct From52w Low
28.52%

Related